Works matching IS 14642662 AND DT 2013 AND VI 14

Results: 118
    1

    British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013.

    Published in:
    HIV Medicine, 2013, v. 14, p. 1, doi. 10.1111/hiv.12106
    By:
    • Wilkins, Ed;
    • Nelson, Mark;
    • Agarwal, Kosh;
    • Awoyemi, Dola;
    • Barnes, Eleanor;
    • Bhagani, Sanjay;
    • Brook, Gary;
    • Brown, Ashley;
    • Castelino, Sheena;
    • Cooke, Graham;
    • Fisher, Martin;
    • Geretti, Anna Maria;
    • James, Robert;
    • Kulasegaram, Ranjababu;
    • Leen, Clifford;
    • Mutimer, David;
    • Orkin, Chloe;
    • Page, Emma;
    • Palfreeman, Adrian;
    • Papineni, Padmasayee
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues.

    Published in:
    HIV Medicine, 2013, v. 14, n. 9, p. 571, doi. 10.1111/hiv.12044
    By:
    • Santoro, MM;
    • Sabin, C;
    • Forbici, F;
    • Bansi, L;
    • Dunn, D;
    • Fearnhill, E;
    • Boumis, E;
    • Nicastri, E;
    • Antinori, A;
    • Palamara, G;
    • Callegaro, A;
    • Francisci, D;
    • Zoncada, A;
    • Maggiolo, F;
    • Zazzi, M;
    • Perno, CF;
    • Ceccherini‐Silberstein, F;
    • Mussini, C
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34

    An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy An undetectable polymerase chain reaction signal in routine HIV plasma viral load monitoring is associated with better virological outcomes in patients receiving highly active antiretroviral therapy

    Published in:
    HIV Medicine, 2013, v. 14, n. 8, p. 509, doi. 10.1111/hiv.12041
    By:
    • Pugliese, P;
    • Delpierre, C;
    • Cuzin, L;
    • Poizot‐Martin, I;
    • Rey, D;
    • Saune, K;
    • Cottalorda, J;
    • Bettinger, D;
    • Delaugerre, C;
    • Hoen, B
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [ Agence Nationale de Recherches sur le SIDA et les Hépatites Virales ( ANRS) 132 SMILE] Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [ Agence Nationale de Recherches sur le SIDA et les Hépatites Virales ( ANRS) 132 SMILE]

    Published in:
    HIV Medicine, 2013, v. 14, n. 7, p. 410, doi. 10.1111/hiv.12021
    By:
    • Lafaurie, M;
    • Dolivo, M;
    • Girard, P‐M;
    • May, T;
    • Bouchaud, O;
    • Carbonnel, E;
    • Madelaine, I;
    • Loze, B;
    • Porcher, R;
    • Molina, J‐M
    Publication type:
    Article
    49
    50